We are live on
!
Find out more
EPGL
Evelyn Partners Group Ltd Portfolio holdings
AUM
$46.9B
This Fund
S&P 500
This Quarter
Est. Return
-2.15%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$46.9B
AUM Growth
–
Cap. Flow
+$5.86B
Cap. Flow
% of AUM
12.5%
Top 10 Holdings %
Top 10 Hldgs %
93.6%
Holding
551
New
551
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$421M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$409M |
| 3 |
Amazon
AMZN
|
+$395M |
| 4 |
Microsoft
MSFT
|
+$378M |
| 5 |
NVIDIA
NVDA
|
+$261M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 89.62% |
| 2 | Technology | 2.91% |
| 3 | Financials | 2.09% |
| 4 | Communication Services | 1.32% |
| 5 | Consumer Discretionary | 1.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
CVS Health
CVS
$122B
| $186K | ﹤0.01% |
+1,800
| New | +$161K |
|
|
BNY
277
Bank of New York Mellon
BNY
$107B
| $184K | ﹤0.01% |
+1,271
| New | +$174K |
|
278
Travelers Companies
TRV
$80.2B
| $175K | ﹤0.01% |
+529
| New | +$160K |
|
279
American Electric Power
AEP
$68.4B
| $171K | ﹤0.01% |
+1,250
| New | +$165K |
|
280
KLA
KLAC
$259B
| $169K | ﹤0.01% |
+560
| New | +$111K |
|
281
Applied Materials
AMAT
$428B
| $166K | ﹤0.01% |
+230
| New | +$106K |
|
282
Marvell Technology
MRVL
$196B
| $164K | ﹤0.01% |
+550
| New | +$110K |
|
283
Deutsche Bank
DB
$71.5B
| $157K | ﹤0.01% |
+4,641
| New | +$150K |
|
284
Autodesk
ADSK
$52.6B
| $154K | ﹤0.01% |
+790
| New | +$180K |
|
285
Wells Fargo
WFC
$264B
| $152K | ﹤0.01% |
+1,836
| New | +$148K |
|
286
Oracle
ORCL
$423B
| $146K | ﹤0.01% |
+995
| New | +$180K |
|
287
ICICI Bank
IBN
$108B
| $139K | ﹤0.01% |
+4,801
| New | +$130K |
|
288
WD-40
WDFC
$3.15B
| $139K | ﹤0.01% |
+570
| New | +$122K |
|
289
Amplify Etho Climate Leadership US ETF
ETHO
$195M
| $138K | ﹤0.01% |
+1,403
| New | +$104K |
|
|
GAM
290
General American Investors Company
GAM
$1.61B
| $135K | ﹤0.01% |
+2,125
| New | +$135K |
|
291
Ecolab
ECL
$79.9B
| $135K | ﹤0.01% |
+486
| New | +$128K |
|
292
US Bancorp
USB
$99.6B
| $134K | ﹤0.01% |
+2,220
| New | +$124K |
|
293
Capital One
COF
$134B
| $134K | ﹤0.01% |
+667
| New | +$128K |
|
294
Infosys
INFY
$50.7B
| $132K | ﹤0.01% |
+12,600
| New | +$158K |
|
295
Carrier Global
CARR
$52.8B
| $130K | ﹤0.01% |
+1,775
| New | +$116K |
|
296
Nutrien
NTR
$30.7B
| $130K | ﹤0.01% |
+2,066
| New | +$144K |
|
|
P
297
Everpure Inc
P
$29.9B
| $130K | ﹤0.01% |
+1,650
| New | +$121K |
|
298
Ciena
CIEN
$58.4B
| $123K | ﹤0.01% |
+250
| New | +$127K |
|
299
Royal Gold
RGLD
$19.5B
| $122K | ﹤0.01% |
+612
| New | +$142K |
|
300
Cheniere Energy
LNG
$52.9B
| $122K | ﹤0.01% |
+509
| New | +$127K |
|
Similar funds
TI
LP
RIM
Evelyn Partners Group Ltd's Q2 2026 Portfolio in Review
Q2 2026 is the first quarter with a 13F filing on record for Evelyn Partners Group Ltd, which disclosed 551 positions worth $46.9B. Its ten largest holdings account for 94% of the portfolio.
Its largest position is AstraZeneca: 2,237,205 shares worth $41.5B.
By sector, the portfolio is most concentrated in Healthcare at 90% of assets, followed by Technology and Financials.
- Evelyn Partners Group Ltd's largest Q2 2026 buy was AstraZeneca: 2,237,205 shares worth $41.5B.
- Evelyn Partners Group Ltd's ten largest holdings make up 94% of its $46.9B portfolio in Q2 2026.
- Evelyn Partners Group Ltd disclosed 551 positions in Q2 2026, its first 13F filing on record.
Based on Evelyn Partners Group Ltd's 13F filing for Q2 2026, filed 7 Aug 2026.